High levels of ER or EGFR showed a significant correlation with poor overall survival in NSCLC patients, suggesting that the ER‐triggered EGFR signaling axis promotes tumor progression [30, 31]. This evidence concerns the gene ESR1 and non-small cell lung carcinoma.